{"AllianceGenome": "24827", "HGNC": "24827", "MIM": "609163", "_id": "338442", "_version": 1, "accession": {"genomic": ["AB065665.1", "AB065876.1", "AB083632.1", "AC026333.28", "AX646475.1", "CP068266.2", "EU012026.1", "KU285440.1", "NC_000012.12", "NC_060936.1"], "protein": ["AAH27965.1", "AAH56419.1", "AAN71621.1", "ABS29270.1", "APT70322.1", "BAB89345.1", "BAC05891.1", "BAC06094.1", "BAF83604.1", "CAD69365.1", "NP_808219.1", "Q8TDS4.1"], "rna": ["AK290915.1", "AL572062.2", "AL698846.1", "AY148884.1", "BC027965.1", "BC056419.1", "BC063461.1", "CD364466.1", "NM_177551.4"], "translation": [{"protein": "AAN71621.1", "rna": "AY148884.1"}, {"protein": "NP_808219.1", "rna": "NM_177551.4"}, {"protein": "BAF83604.1", "rna": "AK290915.1"}, {"protein": "AAH27965.1", "rna": "BC027965.1"}, {"protein": "AAH56419.1", "rna": "BC056419.1"}]}, "alias": ["GPR109A", "HCA2", "HM74a", "HM74b", "NIACR1", "PUMAG", "Puma-g"], "ensembl": {"gene": "ENSG00000182782", "protein": "ENSP00000375066", "transcript": "ENST00000328880", "translation": [{"protein": "ENSP00000375066", "rna": "ENST00000328880"}], "type_of_gene": "protein_coding"}, "entrezgene": "338442", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 4.84572384, "exp_mis": 144.0795673, "exp_syn": 60.15855, "lof_z": 0.830571615374609, "mis_z": 2.52967160167625, "mu_lof": 3.90692455281e-07, "mu_mis": 1.26794166465e-05, "mu_syn": 5.27258241986e-06, "n_lof": 3.0, "n_mis": 82.0, "n_syn": 42.0, "p_li": 0.0201092731074374, "p_null": 0.235945017181035, "p_rec": 0.743945709711527, "syn_z": 1.45138268478385}, "bp": 1092, "cds_end": 123187830, "cds_start": 123186738, "n_exons": 1, "nonpsych": {"exp_lof": 4.3652122, "exp_mis": 130.3852803, "exp_syn": 54.4286583, "lof_z": 0.641725699039459, "mis_z": 2.31396493824121, "mu_lof": 3.90692455281e-07, "mu_mis": 1.26794166465e-05, "mu_syn": 5.27258241986e-06, "n_lof": 3.0, "n_mis": 78.0, "n_syn": 37.0, "p_li": 0.0179895026981002, "p_null": 0.286534472631724, "p_rec": 0.695476024670176, "syn_z": 1.48735169230209}, "nontcga": {"exp_lof": 4.45605478, "exp_mis": 132.5512005, "exp_syn": 55.343858, "lof_z": 0.680430388747441, "mis_z": 2.40387274323687, "mu_lof": 3.90692455281e-07, "mu_mis": 1.26794166465e-05, "mu_syn": 5.27258241986e-06, "n_lof": 3.0, "n_mis": 77.0, "n_syn": 39.0, "p_li": 0.017478962516987, "p_null": 0.264309298689397, "p_rec": 0.718211738793615, "syn_z": 1.39104822994841}, "transcript": "ENST00000328880.5"}, "exons": [{"cdsend": 122703283, "cdsstart": 122702191, "chr": "12", "position": [[122701292, 122703357]], "strand": -1, "transcript": "NM_177551", "txend": 122703357, "txstart": 122701292}], "exons_hg19": [{"cdsend": 123187830, "cdsstart": 123186738, "chr": "12", "position": [[123185839, 123187904]], "strand": -1, "transcript": "NM_177551", "txend": 123187904, "txstart": 123185839}], "generif": [{"pubmed": 12646212, "text": "HM74b has high similarity to HM74 is a receptor for nicotinic acid [HM74b]"}, {"pubmed": 16018973, "text": "Our results provided direct evidence indicating that HM74A, but not HM74, was sufficient to mediate anti-lipolytic effect of niacin in adipose tissue."}, {"pubmed": 16674924, "text": "However, the synergistic effects of HM74A were not dramatically affected by co-treatment with both inhibitors, indicating the cross-talk occurred at the receptor level."}, {"pubmed": 17932499, "text": "neutrophils express functional GPR109A receptors,which might be involved in the regulation of neutrophil numbers"}, {"pubmed": 18639743, "text": "Data show that the high-affinity niacin receptor HM74A is significantly down-regulated in the anterior cingulate cortex of individuals with schizophrenia."}, {"pubmed": 18787507, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19136666, "text": "Data show that many phenolic acids, including those from the hydroxybenzoic and hydroxycinnamic acid classes, can bind and activate GPR109A (HM74a/PUMA-G), the receptor for the antidyslipidemic agent nicotinic acid."}, {"pubmed": 19141678, "text": "GPR109A receptor plays an important role in the dual regulation of adiponectin secretion and lipolysis"}, {"pubmed": 19502010, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 19633298, "text": "Data show that the coordinated PPARgamma-mediated regulation of the GPR81, GPR109A and GPR109B presents a novel mechanism by which TZDs may reduce circulating free fatty acid levels and perhaps ameliorate insulin resistance in obese patients."}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20184326, "text": "Data show that Mk-6892 was discovered as full and potent niacin receptor (GPR109A) agonist."}, {"pubmed": 20380810, "text": "these results demonstrate that GPR109A and GPR109B dimerization is a constitutive process occurring early during biosynthesis."}, {"pubmed": 20460384, "text": "The agonist-induced internalization of GPR109A receptors is regulated by GRK2 and arrestin3 in a pertussis toxin-sensitive manner and that internalized receptor recycling is independent of endosomal acidification."}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20655299, "text": "niacin-mediated activation of GP109A in liver lowers ABCA1 expression leading to reduced hepatic cholesterol efflux to high density lipoprotein."}, {"pubmed": 21655214, "text": "In contrast, in a squamous cell carcinoma derived cell line, both GPR109A and GPR109B show a more diffuse cellular localization and the receptors are nearly non-functional."}, {"pubmed": 21768093, "text": "upon binding to niacin GPR109A receptors initially activate G(i), leading to dissociation of the Gbetagamma subunit from activated G(i), and subsequently induce ERK1/2 activation via two distinct pathways."}, {"pubmed": 22267479, "text": "Nicotnic acid displays a range of effects that are lipoprotein-independent and potentially antiatherogenic. These effects are mediated by GPR109A."}, {"pubmed": 22962331, "text": "A sequence from residues 329 to 343 in the C-terminal tail of HCA plays a crucial role in keeping HCA in an inactive conformation."}, {"pubmed": 23526298, "text": "Review of the role of GPR109A and its downstream effects in the context of atherosclerosis and vascular inflammation, along with insights into strategy for future drug development. [Review Article]"}, {"pubmed": 23658787, "text": "despite NA's anti-inflammatory effect on human macrophages, it has no effect on foam cells in reverse cholesterol transport; due to GPR109A down-regulation"}, {"pubmed": 23770183, "text": "These studies provide key insights into mechanisms by which GPR109A may influence cholesterol efflux in macrophages."}, {"pubmed": 24215154, "text": "Although its functional role is still unknown, HCA2 may be potentially involved in the pathogenesis of various retinopathies and may offer a new therapeutic target."}, {"pubmed": 24371223, "text": "GPR109A is a tumor suppressor in mammary gland."}, {"pubmed": 24662263, "text": "the promiscuous activity exerted by niacin via both GPR109A and GPER may open new avenues towards a better understanding of the mechanisms involved in its biological action exerted in different pathophysiological conditions, including malignant diseases."}, {"pubmed": 25329911, "text": "GPR109A expression is upregulated in blood and substantia nigra in Parkinson disease patients."}, {"pubmed": 25361930, "text": "The results of this study suggested that GPR109A signaling is associated with T2DM, playing a role in regulation of the inflammatory cytokines."}, {"pubmed": 25375133, "text": "These results suggest that the PKC pathway and PDGFR/EGFR transactivation pathway play important roles in HCA2-mediated Akt activation."}, {"pubmed": 25463108, "text": "niacin, at a relatively low concentration, preserves the ability of HMVEC to form tubes under conditions of saturated fatty acid excess, and may elicit this effect through activation of GPR109A"}, {"pubmed": 25690651, "text": "Results suggest that the atypical motif asparaging-cysteine-systeine Asn(17)-Cys(18)-Cys(19) is crucial for the normal surface trafficking and function of hydroxycarboxylic acid receptor 2 protein hGPR109A."}, {"pubmed": 26656756, "text": "new insights into the G protein coupling profiles of the HCA receptors and the function of the receptor's C terminus"}, {"pubmed": 27570060, "text": "These results demonstrate that GPR109A is functionally expressed in both human and murine islet beta-cells."}, {"pubmed": 29263047, "text": "GPR109A may inhibit inflammatory cytokine production, induced by palmitic acid, by MIN6 cells possibly via inhibiting the Akt/mTOR signaling pathway."}, {"pubmed": 30659164, "text": "These results indicate that during aging, GPR109A modulates de novo lipid accumulation in liver and adipose tissue, and its dysregulation can lead to age-associated obesity and hepatic steatosis."}, {"pubmed": 31617441, "text": "This review summarizes the use of niacin in treatment of dyslipidemia, the pharmacogenetics of niacin response and the potential role of HCAR2 signaling in the treatment of a variety of inflammatory and metabolic diseases."}, {"pubmed": 31734354, "text": "C. butyricum decreased the fecal secondary BA contents, increased the cecal SCFA quantities, and activated G-protein coupled receptors (GPRs), such as GPR43 and GPR109A.  The analysis of clinical specimens revealed that the expression of GPR43 and GPR109A gradually decreased from human normal colonic tissue to adenoma to carcinoma"}, {"pubmed": 31858105, "text": "Niacin Ameliorates Hepatic Steatosis by Inhibiting De Novo Lipogenesis Via a GPR109A-Mediated PKC-ERK1/2-AMPK Signaling Pathway in C57BL/6 Mice Fed a High-Fat Diet."}, {"pubmed": 32039055, "text": "Hydroxycarboxylic Acid Receptor 2 Is a Zika Virus Restriction Factor That Can Be Induced by Zika Virus Infection Through the IRE1-XBP1 Pathway."}, {"pubmed": 34777363, "text": "GPR Expression in Intestinal Biopsies From SCT Patients Is Upregulated in GvHD and Is Suppressed by Broad-Spectrum Antibiotics."}, {"pubmed": 34852802, "text": "Rare and potentially pathogenic variants in hydroxycarboxylic acid receptor genes identified in breast cancer cases."}, {"pubmed": 37578011, "text": "Ebola Virus Infection Induces HCAR2 Expression Leading to Cell Death."}, {"pubmed": 37932263, "text": "Structural basis for ligand recognition and signaling of hydroxy-carboxylic acid receptor 2."}, {"pubmed": 37933650, "text": "[GPR109A partly mediates inhibitory effects of beta-hydroxybutyric acid on lung adenocarcinoma cell proliferation, migration and invasion]."}, {"pubmed": 38007572, "text": "Parabacteroides distasonis ameliorates insulin resistance via activation of intestinal GPR109a."}], "genomic_pos": {"chr": "12", "end": 122703357, "ensemblgene": "ENSG00000182782", "start": 122701293, "strand": -1}, "genomic_pos_hg19": {"chr": "12", "end": 123187890, "start": 123185840, "strand": -1}, "go": {"BP": [{"evidence": "IDA", "gocategory": "BP", "id": "GO:0001781", "pubmed": 17932499, "qualifier": "involved_in", "term": "neutrophil apoptotic process"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0007186", "qualifier": "involved_in", "term": "G protein-coupled receptor signaling pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0033031", "pubmed": 17932499, "qualifier": "involved_in", "term": "positive regulation of neutrophil apoptotic process"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0050995", "qualifier": "involved_in", "term": "negative regulation of lipid catabolic process"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0070165", "qualifier": "involved_in", "term": "positive regulation of adiponectin secretion"}], "CC": [{"evidence": "IBA", "gocategory": "CC", "id": "GO:0005886", "qualifier": "is_active_in", "term": "plasma membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005886", "pubmed": 17932499, "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0030054", "qualifier": "located_in", "term": "cell junction"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0070553", "qualifier": "enables", "term": "nicotinic acid receptor activity"}, {"category": "MF", "evidence": "ISS", "id": "GO:0070553", "qualifier": "enables", "term": "nicotinic acid receptor activity"}]}, "homologene": {"genes": [[9598, 452411], [9606, 338442], [10090, 80885], [10116, 353250]], "id": 4391}, "interpro": [{"desc": "G protein-coupled receptor, rhodopsin-like", "id": "IPR000276", "short_desc": "GPCR_Rhodpsn"}, {"desc": "GPCR, rhodopsin-like, 7TM", "id": "IPR017452", "short_desc": "GPCR_Rhodpsn_7TM"}], "ipi": "IPI00157746", "map_location": "12q24.31", "name": "hydroxycarboxylic acid receptor 2", "other_names": ["G protein-coupled receptor HM74a", "G-protein coupled receptor 109A", "G-protein coupled receptor HM74A", "hydroxy-carboxylic acid receptor 2", "hydroxycarboxylic acid receptor 2", "niacin receptor 1", "nicotinic acid receptor"], "pantherdb": {"HGNC": "24827", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1933383", "ortholog_type": "LDO", "panther_family": "PTHR46048", "taxid": 10090, "uniprot_kb": "Q9EP66"}, {"RGD": "727952", "ortholog_type": "LDO", "panther_family": "PTHR46048", "taxid": 10116, "uniprot_kb": "Q80Z39"}, {"ZFIN": "ZDB-GENE-111111-10", "ortholog_type": "O", "panther_family": "PTHR46048", "taxid": 7955, "uniprot_kb": "F1QUW3"}, {"ZFIN": "ZDB-GENE-081107-48", "ortholog_type": "O", "panther_family": "PTHR46048", "taxid": 7955, "uniprot_kb": "E9QFZ4"}], "uniprot_kb": "Q8TDS4"}, "pathway": {"kegg": {"id": "hsa04024", "name": "cAMP signaling pathway - Homo sapiens (human)"}, "reactome": [{"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-3296197", "name": "Hydroxycarboxylic acid-binding receptors"}, {"id": "R-HSA-372790", "name": "Signaling by GPCR"}, {"id": "R-HSA-373076", "name": "Class A/1 (Rhodopsin-like receptors)"}, {"id": "R-HSA-388396", "name": "GPCR downstream signalling"}, {"id": "R-HSA-418594", "name": "G alpha (i) signalling events"}, {"id": "R-HSA-500792", "name": "GPCR ligand binding"}], "wikipathways": {"id": "WP4754", "name": "IL-18 signaling pathway"}}, "pdb": ["7XK2", "7ZL9", "7ZLY", "8H2G", "8I7V", "8I7W", "8IHB", "8IHF", "8IHH", "8IHI", "8IJ3", "8IJA", "8IJB", "8IJD", "8IY9", "8IYH", "8IYW", "8J6I", "8J6J", "8J6L", "8J6P", "8J6Q", "8J6R", "8JER", "8JHN", "8JHY", "8JII", "8JIL", "8JIM", "8JZ7", "8K5B", "8K5C", "8K5D"], "pfam": "PF00001", "pharmgkb": "PA165961843", "pharos": {"target_id": 15923, "tdl": "Tclin"}, "prosite": "PS50262", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF272211", "relationship": "is"}, {"id": "GNF272212", "relationship": "is"}, {"id": "GNF272213", "relationship": "is"}, {"id": "GNF272214", "relationship": "is"}], "GNF_hs-GPCR_IDT-siRNA": [{"id": "GNF281264", "relationship": "is"}, {"id": "GNF281265", "relationship": "is"}, {"id": "GNF281266", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF131024", "relationship": "is"}, "NOVART_hs-genome_siRNA": {"id": "GNF133090", "relationship": "is"}}, "refseq": {"genomic": ["NC_000012.12", "NC_060936.1"], "protein": "NP_808219.1", "rna": "NM_177551.4", "translation": {"protein": "NP_808219.1", "rna": "NM_177551.4"}}, "reporter": {"HTA-2_0": "TC12002078.hg.1", "HuEx-1_0": ["3475782", "3475794"], "HuGene-1_1": "7967318", "HuGene-2_1": "16771797"}, "summary": "Predicted to enable nicotinic acid receptor activity. Involved in neutrophil apoptotic process and positive regulation of neutrophil apoptotic process. Located in cell junction and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]", "symbol": "HCAR2", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1539603"}, "unigene": "Hs.524812", "uniprot": {"Swiss-Prot": "Q8TDS4", "TrEMBL": "A0A4Y1JWQ0"}, "wikipedia": {"url_stub": "Niacin receptor 1"}}